Purpose <p>This study evaluated the anti-amoebic properties of aqueous extracts of two <i>Carica papaya</i> callus clones, Wild Type (Pcc-WT-AE) and KETc7-expressing (Pcc-KETc7-AE) clones, in in vitro and in vivo assays.</p> Methods <p><i>E. histolytica</i> trophozoites cultures were exposed for 24&#xa0;h to varying concentrations of the <i>C. papaya</i> aqueous extracts, and their viability and IC<sub>50</sub> determined by MTT assays. In in vivo studies, golden hamsters were infected intraportally with <i>E. histolytica</i> trophozoites and orally treated with the <i>C. papaya</i> aqueous extracts for 7 days. The animals were sacrificed on day 8, and the development of ALA was recorded. Comparisons were made against metronidazole (MTZ).</p> Results <p>Both extracts statistically reduced trophozoite viability at 24&#xa0;h in a dose-dependent manner in vitro. Pcc-KETc7-AE showed activity to the same extent as MTZ (IC<sub>50</sub> 36.08&#xa0;µg/ml vs. 33.54&#xa0;µg/ml, respectively), whereas Pcc-WT-AE exhibited less efficient but significant activity (IC<sub>50</sub> 113.4&#xa0;µg/ml). Cell death analysis indicated that both extracts killed trophozoites by necrosis. In vivo studies showed that oral treatment with Pcc-WT-AE (4 and 8&#xa0;mg/dose/hamster) completely prevented ALA development in 80% of animals, comparable to the effect of MTZ. In contrast, oral treatment with Pcc-KETc7-AE did not prevent lesions, but statistically reduced hepatomegaly, ALA size, and necrotic areas in tissue sections.</p> Conclusion <p>The aqueous extracts from <i>C. papaya</i> embryogenic callus cultures analyzed here exhibit potent, yet variable, anti-<i>E. histolytica</i> activity in both in vitro and in vivo studies. The activity was nearly as effective as MTZ suggesting their potential use as a new, natural and safe oral treatment for amebiasis.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Aqueous Extracts of Carica papaya Embryogenic Callus Kill Entamoeba histolytica Trophozoites and Orally Protect against the Development of Amoebic Liver Abscesses in Hamsters

  • Cynthia Guzmán,
  • María Luisa Villareal-Ortega,
  • Nelly Villalobos,
  • Anabel Ortiz-Caltempa,
  • Marisela Hernández,
  • Mario Néquiz-Avendaño,
  • Luisa-Carolina González-Ramírez,
  • Gladis Fragoso,
  • Edda Sciutto,
  • César Díaz-Godínez,
  • Julio César Carrero

摘要

Purpose

This study evaluated the anti-amoebic properties of aqueous extracts of two Carica papaya callus clones, Wild Type (Pcc-WT-AE) and KETc7-expressing (Pcc-KETc7-AE) clones, in in vitro and in vivo assays.

Methods

E. histolytica trophozoites cultures were exposed for 24 h to varying concentrations of the C. papaya aqueous extracts, and their viability and IC50 determined by MTT assays. In in vivo studies, golden hamsters were infected intraportally with E. histolytica trophozoites and orally treated with the C. papaya aqueous extracts for 7 days. The animals were sacrificed on day 8, and the development of ALA was recorded. Comparisons were made against metronidazole (MTZ).

Results

Both extracts statistically reduced trophozoite viability at 24 h in a dose-dependent manner in vitro. Pcc-KETc7-AE showed activity to the same extent as MTZ (IC50 36.08 µg/ml vs. 33.54 µg/ml, respectively), whereas Pcc-WT-AE exhibited less efficient but significant activity (IC50 113.4 µg/ml). Cell death analysis indicated that both extracts killed trophozoites by necrosis. In vivo studies showed that oral treatment with Pcc-WT-AE (4 and 8 mg/dose/hamster) completely prevented ALA development in 80% of animals, comparable to the effect of MTZ. In contrast, oral treatment with Pcc-KETc7-AE did not prevent lesions, but statistically reduced hepatomegaly, ALA size, and necrotic areas in tissue sections.

Conclusion

The aqueous extracts from C. papaya embryogenic callus cultures analyzed here exhibit potent, yet variable, anti-E. histolytica activity in both in vitro and in vivo studies. The activity was nearly as effective as MTZ suggesting their potential use as a new, natural and safe oral treatment for amebiasis.